Oxford Textbook of Interventional Cardiology

Cardiac catheterization and coronary angiography remain key tools in the management of patients with coronary heart disease. Although this is the most frequently used method of coronary revascularization, general training in cardiology rarely offers more than the opportunity to assist a more senior operator to perform angioplasty procedures.
This textbook, covering key procedures and fully revised and updated to include the latest trials, technology, and new techniques, is essential reading. The Oxford Textbook of Interventional Cardiology 2nd edition spans the whole spectrum of interventional cardiology procedures, including a novel section on the future of interventional cardiology, and multiple new chapters covering Special devices in percutaneous coronary intervention. Written by an expert team of international authors, this book offers guidance on all aspects of interventional cardiology according the European curriculum, and covers the evidence-based guidelines for a comprehensive view of the field.
· Contains over 400 illustrations and full-colour photographs to aid understanding.
· Based on the European curriculum and guidelines for practice.

Contents

Background and basics
1: The epidemiology and pathophysiology of coronary artery disease, Robert Henderson, Richard Varcoe
2: The history of interventional cardiology, Toby Rogers, Kenneth Kent, and Augusto D. Pichard
3: Risk assessment and analysis of outcomes, Peter F. Ludman
4: Vascular access: femoral versus radial, David H. Roberts
5: Radiation and percutaneous coronary intervention, Gurbir Bhatia, James Nolan
6: The 'golden rules' of percutaneous coronary intervention, Rod Stables
7: Routine management after percutaneous coronary intervention, Kevin O'Gallagher, Jonathan Byrne, and Philip MacCarthy
8: Trial design and interpretation: statistics in PCI, Ayman Al-Saleh and Sanjit Jolly
Percutaneous coronary intervention-related imaging
9: Angiography: indications and limitations, David Adlam, Annette Maznyczka, and Bernard Prendergast
10: Coronary physiology in clinical practice, Olivier Muller, Stephane Fournier, Bernard De Bruyne
11: The role of intravascular ultrasound in percutaneous coronary intervention, Hiromasa Otake, Yasuhiro Honda, and Peter J. Fitzgerald
12: Optical Coherence Tomography in Percutaneous Coronary Intervention, Ravinay Bhindi and Keith M. Channon
13: Coronary computed tomography for the interventionalist, A. Coenen, L.E. Swart, R.P.J. Budde, and K. Nieman
14: Cardiovascular magnetic resonance, Theodoros D. Karamitsos and Stefan Neubauer
Percutaneous coronary intervention by clinical syndrome
15: Stable coronary artery disease: medical therapy versus percutaneous coronary intervention versus surgery, Vasim Farooq and Patrick W. Serruys
16: Percutaneous coronary intervention in non-ST elevation acute coronary syndrome, Bashir Alaour, Michael Mahmoudi and Nick Curzen
17: Primary percutaneous coronary intervention for ST elevation myocardial infarction, Zulfiquar Adam and Mark A. de Belder
18: Percutaneous coronary intervention in patients with impaired left ventricular function, Divaka Perera and Natalia Briceno
Percutaneous coronary intervention by lesion and patient subsets
19: Coronary bifurcation stenting: state of the art, Yves Louvard, Philippe Garot, Thomas Hovasse, Bernard Chevalier, and Thierry Lefèvre
20: Percutaneous coronary intervention for unprotected and protected left main stem disease, Michael Mahmoudi, Nick Curzen, Christine Hughes, Bruno Farah, and Jean Fajadet
21: Chronic total occlusions, Colm G. Hanratty, James C. Spratt, Simon J. Walsh
22: Revascularisation in patients with diabetes mellitus, George Kassimis and Adrian P. Banning
23: Out of Hospital Arrest: Role of PCI, Marko Noc and Peter Radsel
Adjunctive drug therapies in percutaneous coronary intervention
24: Current status of oralantiplatelet therapies, Vikram Khanna, Tony Gershlick and Nick Curzen
25: Current status of GP IIb/IIIa inhibitors, Tim Lockie
26: The role of bivalirudin in percutaneous coronary intervention, Stefanie Schüpke, Steffen Massberg, and Adnan Kastrati
27: Optimal medical therapy in percutaneous coronary intervention patients: statins and ACE inhibitors as disease-modifying agents, Simon J. Corbett and Nick Curzen
28: New Oral Anti-Coagulants (NOACs) and other Adjunctive Therapies, Mikhail S. Dzeshka, Richard A. Brown, and Gregory Y.H. Lip
Complications of percutaneous coronary intervention
29: Contrast-induced acute kidney injury, Peter A. McCullough
30: In-stent restenosis in the drug-eluting stent era, Jaya Chandrasekhar, Adriano Caixeta, Philippe Généreux, George Dangas, and Roxana Mehran
31: Stent thrombosis, Nikesh Malik, Amerjeet Banning, and Tony Gershlick
32: Stent loss and retrieval, Adam de Belder
33: Coronary artery perforation, Mark Gunning and Chee Wah Khoo
Special devices in percutaneous coronary intervention
34: Rotational atherectomy, Adam de Belder, Martyn Thomas, and Emanuele Barbato
35: Laser, Peter O'Kane and Simon Redwood
36: Saphenous Vein Graft PCI, Distal Protection and no-reflow, Giovanni Luigi De Maria and Adrian P. Banning
37: Bioresorbable Vascular Scaffolds, Adam J. Brown and Nick E. J. West
38: Access Sites and the TAVI Procedure, Corrado Tamburino, Claudia Ina Tamburino and Sebastiano Immè
39: Selection of TAVI Prostheses, Mohamed Abdel-Wahab and John Jose
40: Co-existent Coronary Artery Disease in Patients Undergoing TAVI: When and When Not to Treat, Muhammed Zeeshan Khawaja and Simon Redwood
41: Transcatheter Mitral Valve Repair, Michael Bellamy and Christopher Baker
42: Transcatheter Mitral Valve Replacement, Ricardo Boix Garibo, Mohsin Uzzaman, Michael Ghosh-Dastidar, and Vinayak Bapat
Other Non-coronary percutaneous interventions
43: Percutaneous device closure of atrial septal defect and patent foramen ovale, Patrick A. Calvert, Bushra S. Rana, Roland Hilling-Smith, and David Hildick-Smith
44: Mitral balloon valvuloplasty, Alec Vahanian, Dominique Himbert, Eric Brochet, Grégory Ducrocq, and Bernard Iung
45: Alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Charles Knight, Saidi Mohiddin, and Constantinos O'Mahony
46: Carotid artery stenting, Iqbal Malik and Mohamed Hamady
47: Left Atrial Appendage Occlusion, Tim Betts
The Future
48: Novel Therapies for Hypertension, Kenneth Chan, Manish Saxena, and Melvin D. Lobo
49: Robotic PCI, Giora Weisz
50: Stem Cell Therapy and Delivery, Fizzah Choudry and Anthony Mathur